Regeneron Pharmaceuticals, Inc. Stock Performance
as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
$576.31$587.67
1.59%
Downside
0.35%
Upside
52 Week's Low
52 Week's High
$476.49$1,165.8518.64%
Downside
99.07%
Upside
Regeneron Pharmaceuticals, Inc. share price movements today
- Previous Close
- $575.06
- Open
- $576.31
- Volume
- 542.8K
- Day's Low - High
- $576.31 - $587.67
- 52 Week Low - High
- $476.49 - $1,165.85
Regeneron Pharmaceuticals, Inc. Historical Returns
- 1 Month Return
- -0.92 %
- 3 Month Return
- + 13.01 %
- 1 Year Return
- -49.85 %
- 3 Year Return
- -19.04 %
- 5 Year Return
- + 1.78 %
Regeneron Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Check Regeneron Pharmaceuticals, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$59.6B
EPS (TTM)
39.3725
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.03%
PE Ratio (TTM)
14.1
Industry PE ratio
16.65525641025641
P/B Ratio
14.1032
PEG Ratio
1.0771
EBITDA
4.5B
Revenue (TTM)
14.2B
Profit Margin
31.37%
Return On Equity TTM
15.34%
Regeneron Pharmaceuticals, Inc. Stock Valuation
Track how Regeneron Pharmaceuticals, Inc. P/E has moved over time to understand its valuation trends.
Regeneron Pharmaceuticals, Inc. in the last 5 years
Lowest (8.61x)
December 31, 2021
Today (14.10x)
September 17, 2025
Industry (16.66x)
September 17, 2025
Highest (24.50x)
September 30, 2024
Today’s Price to Earnings Ratio: 14.10x
Regeneron Pharmaceuticals, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Regeneron Pharmaceuticals, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $59.6B | 1.78% | 14.1 | 31.37% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% |
Stock Returns calculator for Regeneron Pharmaceuticals, Inc. Stock including INR - Dollar returns
The Regeneron Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Regeneron Pharmaceuticals, Inc. investment value today
Current value as on today
₹55,668
Returns
Returns from Regeneron Pharmaceuticals, Inc. Stock
Dollar Returns*
₹4,598 (+4.6%)
Analyst Recommendation on Regeneron Pharmaceuticals, Inc. Stock
Based on 34 analysts
76.47%
Buy
20.59%
Hold
2.94%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Regeneron Pharmaceuticals, Inc.. Average target price of $716.87
Regeneron Pharmaceuticals, Inc. Share Price Target
Get share price movements and forecasts by analysts on Regeneron Pharmaceuticals, Inc..
What analysts predicted
18.31%UPSIDE
Target Price
$716.87
Current Price
$585.64
Analyzed by
34 Analysts
Target
$716.87
Regeneron Pharmaceuticals, Inc. target price $716.87, a slight upside of 18.31% compared to current price of $585.64. According to 34 analysts rating.
Regeneron Pharmaceuticals, Inc. Stock's Interest Amongst Investors
Investment in Regeneron Pharmaceuticals, Inc. Shares on INDmoney has grown by 14.78% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:14.78%Â versus previous 30 day period
Search interest for Regeneron Pharmaceuticals, Inc. Stock has increased by 24% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:24%Â versus previous 30 day period
Regeneron Pharmaceuticals, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Regeneron Pharmaceuticals, Inc. Annual Profit & Loss
All numbers in Millions USD
Regeneron Pharmaceuticals, Inc. Quarterly Cash Flow
All numbers in Millions USD
Regeneron Pharmaceuticals, Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Regeneron Pharmaceuticals, Inc. Stock
Check out the Mutual Funds with significant holdings in Regeneron Pharmaceuticals, Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.10937% | 830 |
 Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth | 0.52462% | 168 |
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.34745% | 1620 |
Global Institutional Holdings in Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. News & Key Events
Today's Timeline - 17 September
Wed, 04:30 PM
-Regeneron announces garetosmab shows over 99% reduction in abnormal bone lesions in Phase 3 trial for FOP.
Wed, 04:40 PM
-Regeneron confirms primary endpoint met in Phase 3 OPTIMA trial for garetosmab in adults with FOP.
Wed, 05:09 PM
-Regeneron reports garetosmab met key goals in Phase 3 study for fibrodysplasia ossificans progressiva.
Today's Timeline - 17 September
Wed, 07:00 PM
-Phase 2 COURAGE trial shows semaglutide combined with trevogrumab reduces lean mass loss significantly.
Wed, 09:59 PM
-Regeneron reports positive results from Phase 3 OPTIMA trial of garetosmab for fibrodysplasia ossificans progressiva.
Wed, 11:57 PM
-Regeneron announces positive Phase 3 trial results for first-in-class antibody-blockers for cat and birch allergies.
Insights on Regeneron Pharmaceuticals, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Regeneron Pharmaceuticals, Inc. has shown strong revenue growth in the last two quarters. Revenue increased from $3.02 billion to $3.67 billion, reflecting an average increase of 17.6% per quarter.
- POSITIVE IMPACT
Profit Spike
Regeneron Pharmaceuticals, Inc. has shown strong profit performance over the last two quarters. The net profit increased from $808.7 million to $1.39 billion, marking an average growth of 41.9% per quarter.
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 118.0%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 135.5%
NEGATIVE IMPACTPrice Dip
In the last 6 months, REGN stock has moved down by -15.2%
About Regeneron Pharmaceuticals, Inc.
| Organisation | Regeneron Pharmaceuticals, Inc. |
| Headquarters | 777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707 |
| Industry | Health Technology |
| CEO | Dr. Leonard S. Schleifer M.D., Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Regeneron Pharmaceuticals, Inc.
Name | Title |
|---|---|
Mr. Ryan Crowe | Senior Vice President of Investor Relations & Strategic Analysis |
Mr. Joseph J. LaRosa J.D. | Executive VP, General Counsel & Secretary |
Dr. Leonard S. Schleifer M.D., Ph.D. | Co-Founder, President, CEO & Co-Chairman |
Mr. Christopher R. Fenimore CPA | Executive VP of Finance & CFO |
Dr. Andrew J. Murphy Ph.D. | Executive Vice President of Research |
Mr. Daniel P. Van Plew | Executive VP and GM of Industrial Operations & Product Supply |
Mr. Rajesh Ahuja | Senior Vice President of Quality Assurance & Operations |
Mr. Bob McCowan | Senior VP of IT & Chief Information Officer |
Ms. Melissa Lozner | Senior VP & Chief Compliance Officer |
Dr. George D. Yancopoulos M.D., Ph.D. | Co-Founder, President, Chief Scientific Officer & Co-Chairman |
FAQs
What is Regeneron Pharmaceuticals, Inc. share price today?
Regeneron Pharmaceuticals, Inc. share price today is $585.64 as on at the close of the market. Regeneron Pharmaceuticals, Inc. share today touched a day high of $587.67 and a low of $576.31.
What is the 52 week high and 52 week low for Regeneron Pharmaceuticals, Inc. share?
Regeneron Pharmaceuticals, Inc. share touched a 52 week high of $1,165.85 on and a 52 week low of $476.49 on . Regeneron Pharmaceuticals, Inc. stock price today i.e. is closed at $585.64,which is 49.77% down from its 52 week high and 22.91% up from its 52 week low.
What is Regeneron Pharmaceuticals, Inc.'s market capitalisation today?
Regeneron Pharmaceuticals, Inc. market capitalisation is $0.06T as on .
How to invest in Regeneron Pharmaceuticals, Inc. Stock (REGN) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Regeneron Pharmaceuticals, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regeneron Pharmaceuticals, Inc. Shares that will get you 0.0026 shares as per Regeneron Pharmaceuticals, Inc. share price of $585.64 per share as on September 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Regeneron Pharmaceuticals, Inc. Stock (REGN) from India?
Indian investors can start investing in Regeneron Pharmaceuticals, Inc. (REGN) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Regeneron Pharmaceuticals, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Regeneron Pharmaceuticals, Inc. share’s latest price of $585.64 as on September 18, 2025 at 1:29 am IST, you will get 0.0171 shares of Regeneron Pharmaceuticals, Inc.. Learn more about
fractional shares .
What are the returns that Regeneron Pharmaceuticals, Inc. has given to Indian investors in the last 5 years?
Regeneron Pharmaceuticals, Inc. stock has given 1.78% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?